Shanghai Bio-heart Biological Technology Co., Ltd.
Climate Impact & Sustainability Data (2023)
Reporting Period: 2023
Environmental Metrics
Total Carbon Emissions:635.72 tCO2e/year
Scope 1 Emissions:18.54 tCO2e/year
Scope 2 Emissions:553.25 tCO2e/year
Scope 3 Emissions:59.18 tCO2e/year
Renewable Energy Share:Not disclosed
Total Energy Consumption:968.60 MWh/year
Water Consumption:1,577.00 m3/year
Waste Generated:0.84 tons/year (0.24 hazardous, 0.70 non-hazardous)
Carbon Intensity:Not disclosed
ESG Focus Areas
- Innovation and Technology
- Quality and Safety of Products and Services
- Intellectual Property Protection
- Business Ethics and Integrity
- Risk Management
Environmental Achievements
- Reduced GHG emissions from 818.53 tonnes in 2022 to 635.72 tonnes in 2023.
- Reduced non-hazardous waste from 1.00 tonnes in 2022 to 0.70 tonnes in 2023.
Social Achievements
- Implemented various employee well-being initiatives, including annual body check program and ergonomic office chairs.
- Provided training to 234.38% of employees, with an average of 6.97 training hours per employee.
Governance Achievements
- Established an ESG task force to monitor and implement ESG-related matters.
- Adopted a Board Diversity Policy to enhance board effectiveness and maintain high corporate governance standards.
Climate Goals & Targets
Long-term Goals:
- Not disclosed
Medium-term Goals:
- Not disclosed
Short-term Goals:
- General reduction of 1% in overall hazardous waste and non-hazardous waste intensity in the upcoming three years.
- General reduction of 1% in overall energy use intensity in the upcoming three years.
- General reduction of 1% in overall water use intensity in the upcoming three years.
- General reduction of 1% in overall emission intensity in the upcoming three years.
Environmental Challenges
- Significant operating losses since inception and potential need for additional financing.
- Lengthy and expensive clinical product development process with uncertain outcomes.
- Limited experience in sales and marketing activities.
- Extensive government regulations and unpredictable approval processes.
- Complex manufacturing process subject to strict quality controls.
- Reliance on a limited number of suppliers.
- Potential product liability claims.
- Competition in the medical device market.
- Risks associated with doing business in China (political and economic changes, legal system uncertainties).
Mitigation Strategies
- Implementing various resource-saving measures (intelligent air-conditioning control, automated purification system, minimized packaging materials).
- Strengthening risk awareness and emergency management, improving forecast and warning mechanisms, enhancing contingency plan operability, and improving coordination in disaster prevention and relief.
- Regularly reviewing salary remuneration and benefits to retain talents.
- Establishing a comprehensive ESG management system with a three-level structure.
- Developing and implementing policies and systems to strengthen compliance management.
- Establishing a quality management system in accordance with GMP standards and ISO 13485:2016.
- Formulating an anti-corruption and anti-bribery policy and providing related training.
- Establishing a whistle-blowing policy to encourage reporting of misconduct.
- Implementing measures to protect intellectual property rights.
- Adopting security safeguard measures to protect data privacy.
Supply Chain Management
Supplier Audits: 147 approved suppliers, annual comprehensive evaluation.
Responsible Procurement
- Compliance with laws and regulations (anti-bribery, anti-corruption, product health safety).
- ESG criteria considered in supplier selection and evaluation.
- ISO13485 quality management system.
Climate-Related Risks & Opportunities
Physical Risks
- Extreme weather events (floods, heavy rainfall) causing delays in product delivery and affecting operational efficiency.
Transition Risks
- Changes in environmental laws and regulations.
Opportunities
- Development of energy-efficient products and processes.
Reporting Standards
Frameworks Used: Appendix C2 of the Rules Governing the Listing of Securities (the “Listing Rules”) issued by the Stock Exchange of Hong Kong Limited
Certifications: ISO 13485:2016
Third-party Assurance: Not disclosed
UN Sustainable Development Goals
- Not disclosed
Not disclosed
Sustainable Products & Innovation
- Not disclosed
Awards & Recognition
- Not disclosed